A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis
Titel:
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis
Auteur:
Henn, Matthew R. O’Brien, Edward J. Diao, Liyang Feagan, Brian G. Sandborn, William J. Huttenhower, Curtis Wortman, Jennifer R. McGovern, Barbara H. Wang-Weigand, Sherry Lichter, David I. Chafee, Meghan Ford, Christopher B. Bernardo, Patricia Zhao, Peng Simmons, Sheri Tomlinson, Amelia D. Cook, David N. Pomerantz, Roger J. Misra, Bharat K. Auninš, John G. Trucksis, Michele